Third dose of mRNA-1273 vaccine induces serologic response in 49 percent of kidney recipients who did not respond after two doses
Monoclonal Antibodies for COVID-19 Effective for Transplant Patients
Favorable outcomes, minimal adverse effects seen in solid organ transplant recipients who received monoclonal antibody therapy for COVID-19
Third COVID-19 Vaccine Dose Tried in Organ Transplant Recipients
Six patients with low-positive antibody levels following standard vaccination achieved high-positive levels after dose 3
Hemodialysis Patients Have Antibody Response to COVID-19 Vaccine
But few kidney transplant recipients develop anti-spike SARS-CoV-2 antibodies after second mRNA vaccine dose
Antibody Response Lags After Second Vaccine Dose in Transplant Recipients
Fifty-four percent of solid organ transplant recipients had antibody response after two doses of SARS-CoV-2 mRNA vaccine
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
Female recipient received lung tissue donated by her husband and son
First U.S. Trachea Transplant Patient Breathing Freely
So far, patient has not had any complications or signs of rejection
Antibody Response to SARS-CoV-2 mRNA Vaccine Poor in Transplant Recipients
Anti-S1 or anti-receptor-binding domain antibody detectable in 17 percent of solid organ transplant recipients after first dose
Transplant Recipient Dies After Receiving COVID-19-Infected Lungs
Surgeon who handled the donor lungs also became infected and fell ill but recovered
Virtual Kidney Transplant Evaluation Possible
Telehealth platform enabled maintenance of wait-list evaluation volume in large kidney transplant program during COVID-19 pandemic